Trexquant Investment’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
64,135
+20,375
| +47% | +$3.52M | 0.12% | 213 |
|
|
2025
Q1 | $6.82M | Buy |
43,760
+16,693
| +62% | +$2.6M | 0.08% | 379 |
|
|
2024
Q4 | $3.73M | Buy |
27,067
+19,010
| +236% | +$2.62M | 0.04% | 629 |
|
|
2024
Q3 | $1.2M | Sell |
8,057
-15,640
| -66% | -$2.34M | 0.02% | 987 |
|
|
2024
Q2 | $3.23M | Buy |
23,697
+3,408
| +17% | +$465K | 0.05% | 553 |
|
|
2024
Q1 | $3.07M | Buy |
20,289
+10,421
| +106% | +$1.58M | 0.06% | 486 |
|
|
2023
Q4 | $1.24M | Buy |
+9,868
| New | +$1.24M | 0.03% | 746 |
|
|
2023
Q1 | – | Sell |
-2,050
| Closed | -$250K | – | 1427 |
|
|
2022
Q4 | $250K | Buy |
+2,050
| New | +$250K | 0.01% | 1164 |
|
|
2021
Q3 | – | Sell |
-2,042
| Closed | -$269K | – | 1118 |
|
|
2021
Q2 | $269K | Buy |
+2,042
| New | +$269K | 0.02% | 766 |
|
|
2021
Q1 | – | Sell |
-3,753
| Closed | -$626K | – | 1109 |
|
|
2020
Q4 | $626K | Buy |
+3,753
| New | +$626K | 0.07% | 377 |
|
|
2018
Q1 | – | Sell |
-6,999
| Closed | -$280K | – | 1055 |
|
|
2017
Q4 | $280K | Sell |
6,999
-1,833
| -21% | -$73.3K | 0.03% | 780 |
|
|
2017
Q3 | $320K | Buy |
8,832
+32
| +0.4% | +$1.16K | 0.08% | 439 |
|
|
2017
Q2 | $244K | Buy |
+8,800
| New | +$244K | 0.07% | 570 |
|